Blood Clot News and Research RSS Feed - Blood Clot News and Research

A Blood Clot is a mass of blood that forms when blood platelets, proteins, and cells stick together. When a blood clot is attached to the wall of a blood vessel, it is called a thrombus. When it moves through the bloodstream and blocks the flow of blood in another part of the body, it is called an embolus.

Researcher develops synthetic hydrogel that promotes natural clotting, heals surgical wounds

Synthetic collagen invented at Rice University may help wounds heal by directing the natural clotting of blood. [More]
Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Pradaxa receives FDA approval for treatment and reduction of risk of recurrence of DVT and PE

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved Pradaxa® (dabigatran etexilate mesylate) for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have been treated with a parenteral anticoagulant for five to 10 days, and to reduce the risk of recurrent DVT and PE in patients who have been previously treated. DVT and PE are collectively referred to as venous thromboembolism (VTE). [More]
Study of non-surgically implanted replacement pulmonary valve shows strong results

Study of non-surgically implanted replacement pulmonary valve shows strong results

The first post-FDA approval study of a non-surgically implanted replacement pulmonary valve showed strong short- and mid-term results for the device in patients with certain congenital heart defects, according to research presented by a U-M pediatric interventional cardiologist at the American College of Cardiology's 63rd Annual Scientific Session Sunday. [More]
Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

Heparin proves effective than bivalirudin in patients receiving percutaneous coronary intervention after heart attack

In a comparison of two blood-thinning medications, heparin was associated with significantly fewer major cardiovascular events at 28 days than bivalirudin in patients receiving primary percutaneous coronary intervention after a heart attack, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Enrollment commences for Daiichi Sankyo's ENSURE-AF multinational phase 3 study in NVAF patients

Daiichi Sankyo Company, Limited today announced that it has started enrolling patients into the ENSURE-AF multinational phase 3 study, which will evaluate the efficacy and safety of its investigational oral, once-daily direct factor Xa-inhibitor edoxaban compared to enoxaparin/warfarin for the prevention of stroke and other blood clot complications in patients with non-valvular atrial fibrillation (NVAF) undergoing electrical cardioversion (low-energy shocks to trigger normal heart rhythm). [More]

ISTH declares Oct.13 as World Thrombosis Day

Bringing together nations and local communities to tackle thrombosis, the quiet, underlying disorder that is the common mechanism of the world's three top cardiovascular killers – heart attack, stroke and venous thromboembolism (VTE) – the International Society on Thrombosis and Haemostasis (ISTH) today announced that October 13 will be designated World Thrombosis Day, with the inaugural event to be held this year. [More]

Study explores how brain restores blood flow to damaged tissue following stroke

A neuroscientist at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech says she hopes that a better understanding of how the brain restores blood flow to damaged tissue following a stroke will offer new treatment clues for a leading cause of death in the United States. [More]

Neuroscientist explores how the brain restores blood flow to damaged tissue following stroke

A neuroscientist at the Virginia-Maryland Regional College of Veterinary Medicine at Virginia Tech says she hopes that a better understanding of how the brain restores blood flow to damaged tissue following a stroke will offer new treatment clues for a leading cause of death in the United States. [More]

Study shows correlation between blood poisoning and risk of blood clots

​Every year, almost 10,000 Danes are admitted to hospital with blood poisoning, while more than 3,000 patients become infected while they are hospitalised. New research shows that Danes suffering from blood poisoning risk an extra challenge in the form of an increased risk of suffering a blood clot: [More]

Bristol-Myers Squibb, Pfizer announce FDA approval of Eliquis for DVT prophylaxis

Bristol-Myers Squibb Company and Pfizer Inc. today announced that the U.S. Food and Drug Administration approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. [More]

Molecular substance that occurs naturally in humans reduces brain damage after acute stroke

A molecular substance that occurs naturally in humans and rats was found to "substantially reduce" brain damage after an acute stroke and contribute to a better recovery, according to a newly released animal study by researchers at Henry Ford Hospital. [More]
Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins combined with conventional blood clot prevention therapies, reduce VTE risk by 48%

Statins have long been known to lower cholesterol and, more recently, to decrease the risk of deep vein thrombosis (blood clots) in healthy, non-surgical patients. [More]

Long-term risks of deep vein thrombosis

Deep vein thrombosis (DVT) often brings with it the risk of post-thrombotic syndrome (PTS), an under-recognized but serious complication that often causes long-term disability for patients. During March's DVT Awareness Month, the Society of Interventional Radiology wants to help patients and family members to better understand the long-term risks of DVT. [More]
1/3 of people who survive stroke before age 50 are unable to live independently

1/3 of people who survive stroke before age 50 are unable to live independently

One-third of people who survive a stroke before age 50 are unable to live independently or need assistance with daily activities 10 years after their stroke, according to research in the American Heart Association journal Stroke. [More]
Researchers receive $3M grant to develop targeted cancer drugs and repair damaged arteries

Researchers receive $3M grant to develop targeted cancer drugs and repair damaged arteries

The National Institutes of Health has awarded grants totaling $3 million for two nanoparticle research projects in which Penn State bioengineer Jian Yang is co-principal investigator. [More]

Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby, says study

​Women's blood clot risk remains elevated for at least 12 weeks after delivering a baby - twice as long as previously recognized, according to a large study presented at the American Stroke Association's International Stroke Conference 2014. [More]
Stroke hospitalization and death rates associated with weather changes

Stroke hospitalization and death rates associated with weather changes

Stroke hospitalization and death rates may rise and fall with changes in environmental temperature and dew point, according to research presented at the American Stroke Association's International Stroke Conference 2014. [More]
UTHealth unveils country's first Mobile Stroke Unit

UTHealth unveils country's first Mobile Stroke Unit

The University of Texas Health Science Center at Houston (UTHealth) Medical School, in partnership with Memorial Hermann-Texas Medical Center, has unveiled the country's first Mobile Stroke Unit. [More]
New vacuum-like tool removes potentially deadly, large clots in hearts

New vacuum-like tool removes potentially deadly, large clots in hearts

Instead of making a chest incision for open heart surgery, cardiovascular surgeons can now use a new vacuum-like tool to remove potentially deadly, large clots that lodge in patients' hearts. [More]

State highlights: N.Y. revises its request for Medicaid adjustment; transplant waiting periods for new coverage in Wash.

A selection of health policy stories from New York, Washington state, California, Virginia, Idaho, Connecticut and Georgia. [More]